The latest on Bayer's Roundup litigation battle

The New Lede Editor-in-Chief Carey Gillam talked with attorney and consumer advocate Whitney di Bona from Drugwatch about a flurry of recent legal maneuvers in the battle over Bayer's proposed $7.25 billion class action settlement of Roundup litigation. The company is hoping to resolve tens of thousands of outstanding lawsuits - and head off future lawsuits - brought by people alleging glyphosate herbicides such as Roundup cause cancer. But critics of the proposed settlement are seeking to derail the deal, saying it's deeply unfair to plaintiffs.